Need More Women For Device Trials? Create Better Consent Forms, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
Enrolling women and minorities in device trials remains a challenge. One potential solution highlighted at a recent FDA meeting: improve communication of potential treatment risks.
You may also be interested in...
Regulatory News In Brief
FDA releases de novo guidance
Regulatory News In Brief
FDA releases de novo guidance
FDA Panel: Transvaginal Mesh For Prolapse Should Be Class III
Current and future surgical mesh devices for pelvic organ prolapse repair would require PMA submissions under a recommendation last week by FDA’s Obstetrics and Gynecology Devices panel.